Zobrazeno 1 - 10 of 39 pro vyhledávání: '"Jayant, Narang"'
5
P-015: Is it time to revisit role of PET-CT imaging and its integration with other parameters in International Myeloma Working Group (IMWG) response assessment criteria?
Autor: Jayant Narang, Zsolt Somodi, Kimberely Fernandes-Thomas, Shweta Narang, Katarina Ludajic, Joseph R. Mikhael, Surabhi Bajpai, Arvin Kheterpal
Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S47
Background The landscape of imaging in multiple myeloma has changed drastically since the publication of IMWG 2016 criteria. 18 F-FDG PET-CT (PET-CT) is being used more frequently, for staging, prognosis and clinical decision making. PET-CT is useful
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cad013a3982553d95aba646eb2aad844
https://doi.org/10.1016/s2152-2650(21)02149-2
Zobrazit plný text záznamu
6
Mantle Cell Lymphoma: Incidence of Gastrointestinal Involvement and Correlation with Overall Response- Retrospective Review of Multiple Multicenter Trials
Autor: Rudresh Jarecha, Shweta Narang, Manish Sharma, Jayant Narang, Surabhi Bajpai, Ravikanth Mankala
Publikováno v: Blood. 136:33-34
Background:Mantle cell lymphoma (MCL) is a rare kind of Non-Hodgkin Lymphoma. The incidence of Gastrointestinal (GI) involvement is an important factor in assessing patients and determining the disease burden, although it has not been studied extensi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0625e3dd900066bcd38d7f9aead6fb84
https://doi.org/10.1182/blood-2020-137657
Zobrazit plný text záznamu
7
The Clinical Relevance of Residual, Persistent and Elongated Abnormal Sized Nodes By Longest Diameter (LDi) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL), Otherwise in a Complete Remission (CR)
Autor: Manish Sharma, Jayant Narang, Surabhi Bajpai, Rudresh Jarecha, Bruce D. Cheson, Christiana Caplan, Gabriele Padrella, Dana Macdonald
Publikováno v: Blood. 136:34-35
Background: IWCLL 2008 and 2018 criteria require that all lymph nodes/nodal masses be ≤ 15mm in longest diameter (LDi) to be consistent with a CR. Lymph nodes or nodal masses >15mm in the LDi are considered abnormal. However, it has been observed t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c6a9671c489a6f2e9db6ad0174d2ec9a
https://doi.org/10.1182/blood-2020-136731
Zobrazit plný text záznamu
8
Imaging determinants of early progression in relapsed and refractory Hodgkin and diffuse large B cell lymphoma
Autor: Ravikanth Mankala, Oliver Bohnsack, Jayant Narang, Rudresh Jarecha, Shweta Narang, Manish Sharma, Surabhi Bajpai, Usha Lalchandani
Publikováno v: Journal of Clinical Oncology. 39:e19522-e19522
e19522 Background: Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma with over 18,000 new cases diagnosed each year in the United States and approximately 7-8 cases per 100.000 people globally. Hodgkin’s Lymphoma
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ba4b898d3249fbdb7664ccd7a2e211f
https://doi.org/10.1200/jco.2021.39.15_suppl.e19522
Zobrazit plný text záznamu
9
To determine correlation of inter reader variability in sum of diameters using RECIST 1.1 with end point assessment in lung cancer
Autor: Manish Sharma, Anitha Singareddy, Michael O'Connor, Surabhi Bajpai, Rudresh Jarecha, Jayant Narang
Publikováno v: Journal of Clinical Oncology. 39:e13557-e13557
e13557 Background: Lung cancer is the leading cause of cancer death in the world including more than 160,000 deaths in the US. The purpose of the study was to determine whether inter reader variability in Sum of Diameters (SOD) of tumor burden has an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::92bf616afc3e62ca5a54f49fce4f3cbd
https://doi.org/10.1200/jco.2021.39.15_suppl.e13557
Zobrazit plný text záznamu
10
Identification of new lesion with disease progression in Ovarian cancer per RECIST 1.1
Autor: Jayant Narang, Oliver Bohnsack, Surabhi Bajpai, Anitha Singareddy, Manish Sharma, Rudresh Jarecha
Publikováno v: Journal of Clinical Oncology. 38:e18058-e18058
e18058 Background: Metastasis is the leading cause of ovarian cancer (OC) related death with more than 70% of OC patients diagnosed with metastasis with five-year survival rates below 45%. OC cells mainly metastasize within the peritoneal cavity at p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1154c76e08f4031c6f408018203d79bc
https://doi.org/10.1200/jco.2020.38.15_suppl.e18058
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje